BETH DOMBROWSKI: Open Payments
NPI 1124448428 · MANSFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$937 in 38 payments from 14 companies in 2025. Trend: 2023 $718 · 2024 $1,060 · 2025 $937
Food & beverage: $937
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $196 |
| ABBVIE INC. | 8 | $167 |
| Novo Nordisk Inc | 6 | $157 |
| PFIZER INC. | 3 | $67 |
| Lilly USA, LLC | 2 | $57 |
| Novartis Pharmaceuticals Corporation | 3 | $57 |
| UCB, Inc. | 2 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| Dexcom, Inc. | 1 | $32 |
Products named: EVENITY, RINVOQ, SKYRIZI, Ozempic, Wegovy, MOUNJARO, LEQVIO, PREVNAR 20.
Industry payments across MA — which companies pay providers there.
